Current Report Filing (8-k)
May 17 2021 - 03:55PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
Date of Report (Date of earliest event reported): May 17, 2021
Medicine Man Technologies, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Nevada |
001-36868 |
46-5289499 |
| (State
or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS
Employer Identification No.) |
|
4880 Havana Street, Suite 201
Denver, Colorado
|
|
80239 |
| (Address of Principal Executive
Offices) |
|
(Zip
Code) |
| |
|
|
| (303) 371-0387 |
| (Registrant’s Telephone Number, Including Area
Code) |
| |
|
|
| Not Applicable |
| (Former Name or Former Address, if Changed Since
Last Report) |
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425) |
| ☐ |
Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
| ☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the
Act:
|
Title of Each
Class |
|
Trading Symbol(s) |
|
Name of Each Exchange On Which
Registered |
| Not
applicable |
|
Not
applicable |
|
Not
applicable |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☒
Item 7.01 Regulation FD Disclosure.
On May 17, 2021, Medicine Man Technologies, Inc. (the “Company”)
participated in the Virtual Road Show Series hosted by Noble
Capital Markets and ChannelChek and presented an updated investor
presentation. A copy of the investor presentation has been posted
to the Company’s website at ir.medicinemantechnologies.com and a
copy thereof is furnished as Exhibit 99.1 to this Current Report on
Form 8-K and incorporated herein by reference.
This Current Report on Form 8-K and the investor presentation
attached hereto as Exhibit 99.1 are being furnished by the Company
pursuant to Item 7.01. In accordance with General Instruction B.2
of Form 8-K, the information contained in this Current Report on
Form 8-K, including Exhibit 99.1 shall not be deemed “filed” for
the purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, or otherwise subject to the liability of that section.
In addition, this information shall not be deemed incorporated by
reference into any of the Company’s filings with the Securities and
Exchange Commission, except as shall be expressly set forth by
specific reference in any such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
| |
MEDICINE MAN
TECHNOLOGIES, INC. |
| |
|
| |
By: |
/s/ Daniel R. Pabon |
|
Date: May 17, 2021
|
|
Daniel R. Pabon
General Counsel |
Medicine Man Technologies (QX) (USOTC:SHWZ)
Historical Stock Chart
From Apr 2022 to May 2022
Medicine Man Technologies (QX) (USOTC:SHWZ)
Historical Stock Chart
From May 2021 to May 2022
